We have patented technologies, with extensive clinical trials, that show how IntraLymphNode Allergen ImmunoTherapy (IL-AIT) can eliminate allergy symptoms for years. 
We are currently raising funds to launch the AlleCures™ platform in the USA. We will be looking to expand our US clinical trials for specific allergens.  We believe the AlleCure™ Platform could eliminate sensitivity to common allergens. 

About AlleCures

 Immunotherapies for Allergic Disease Control


AlleCures is a spinout of Colby Pharmaceuticals. The AlleCures™  platform is based on years of international clinical studies and research. We are committed to creating safe treatment for allergies and developing innovative solutions for medical professionals.  

​​AlleCures Inc

  Trials & Investing